Citations

Clear

3138 citation(s) found for "Smith, AM".

Fluid management and deresuscitation practices – An opportunity for collaboration
Bissell, Brittany D. , Wieruszewski, Patrick M. , Newsome, Andrea S, Verkerk, Brittany S. , Magee, Carolyn, Pajoumand, Mehrnaz, Bell, Carolyn M. , Wieruszewski, Patrick M , Bissell Turpin, Brittany D , Newsome, Andrea S, Witenko, Corey J. , Ammar, Mahmoud A , Magee, Carolyn, Smith, Melanie , Hammond, Drayton A

Mayo Clinic

Journal of the Intensive Care Society | June 16, 2020 | Volume: 24 | Issue: 3_suppl | Pages: 24-26

10.1177/1751143720934386 | PMID 37928092 Get It

The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States
Tai, Don Bambino Geno , Shah, Aditya , Sia, Irene G. , Wieland, Mark L. , Doubeni, Chyke A. , Wieland, Mark L , Tai, Don Bambino Geno , Sia, Irene G

Mayo Clinic

Clinical Infectious Diseases | June 15, 2020 | Volume: 72 | Issue: 4 | Pages: 703-706

10.1093/cid/ciaa815 | PMID 32562416 Get It

Abstract The coronavirus disease 2019 (COVID-19) pandemic has disproportionately affected racial and ethnic minority groups, with high rates of death in African American, Native American, and LatinX communities. Although the mechanisms of these disparities are being investigated, they can be conceived as arising from biomedical factors as well as social determinants of health. Minority groups are disproportionately affected by chronic medical conditions and lower access to healthcare that may portend worse COVID-19 outcomes. Furthermore, minority communities are more likely to experience living and working conditions that predispose them to worse outcomes. Underpinning these disparities are long-standing structural and societal factors that the COVID-19 pandemic has exposed. Clinicians can partner with patients and communities to reduce the short-term impact of COVID-19 disparities while advocating for structural change.
Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities
Armstrong, Nicola J. , Mather, Karen A. , Sargurupremraj, Muralidharan , Knol, Maria J. , Malik, Rainer, Satizábal, Claudia L. , Yanek, Lisa R., Wen, Wei , Guðnason, Vilmundur , Dueker, Nicole , Elliott, Lloyd T. , Hofer, Edith, Bis, Joshua C. , Jahanshad, Neda , Li, Shuo , Logue, Mark, Scholz, Markus , Smith, Albert V. , Trompet, Stella , Alfaro‐Almagro, Fidel , Ames, David, Amin, Najaf , Beiser, Alexa S., Brodaty, Henry , Fennema‐Notestine, Christine , Gampawar, Piyush , Gottesman, Rebecca, Griffanti, Ludovica , Kral, Brian G. , Lampe, Leonie, Liewald, David C. , Maillard, Pauline , Marchini, Jonathan, Bastin, Mark E., Pirpamer, Lukas , Roshchupkin, Gennady V. , Stott, David J., Thalamuthu, Anbupalam , Tzourio, Christophe , Grond, Jeroen van der , Vernooij, Meike W. , Witte, A. Veronica , Wright, Margaret J. , Yang, Qiong, Siggurdsson, Siggi, Psaty, Bruce M., Villringer, Arno , Schmidt, Helena, Duijn, Cornelia M. van , Jukema, J. Wouter , Dichgans, Martin , Sacco, Ralph L., Kremen, William S., Becker, Lewis C. , Thompson, Paul M., Mosley, Thomas H. , Wardlaw, Joanna M. , Ikram, M. Arfan , Adams, Hieab H.H. , Seshadri, Sudha , Sachdev, Perminder S. , Smith, Stephen M. , Launer, L. J., Longstreth, W.T. , DeCarli, Charles , Schmidt, Reinhold, Fornage, Myriam , Debette, Stéphanie , DeCarli, Charles , Dichgans, Martin , Wardlaw, Joanna Marguerite , Thalamuthu, Anbupalam , Wen, Wei , Adams, Hieab H H , Satizabal, Claudia L , Seshadri, Sudha , Brodaty, Henry , Sachdev, Perminder S , Wright, Margaret J , Tzourio, Christophe , van Duijn, Cornelia M , Debette, Stephanie , Smith, Albert V , Maillard, Pauline , Hofer, Edith , Luciano, Michelle , Vojinović, Dina , Xia, Rui , Amouyel, Philippe , Deary, Ian J. , Jack, Clifford R. , Jenkinson, Mark , Jiang, Jiyang , Kwok, John B. , Marchini, Jonathan , Mazoyer, Bernard , Romero, José R. , Schofield, Peter R. , Schroeter, Matthias L , Trollor, Julian N , Morris, Zoë , Psaty, Bruce M. , Håberg, Asta K , Wright, Clinton B. , Thompson, Paul M. , Nyquist, Paul

Mayo Clinic

Stroke | June 10, 2020 | Volume: 51 | Issue: 7 | Pages: 2111-2121

10.1161/strokeaha.119.027544 | PMID 32517579 Get It

Background and Purpose: Periventricular white matter hyperintensities (WMH; PVWMH) and deep WMH (DWMH) are regional classifications of WMH and reflect proposed differences in cause. In the first study, to date, we undertook genome-wide association analyses of DWMH and PVWMH to show that these phenotypes have different genetic underpinnings. Methods: Participants were aged 45 years and older, free of stroke and dementia. We conducted genome-wide association analyses of PVWMH and DWMH in 26,654 participants from CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology), ENIGMA (Enhancing Neuro-Imaging Genetics Through Meta-Analysis), and the UKB (UK Biobank). Regional correlations were investigated using the genome-wide association analyses -pairwise method. Cross-trait genetic correlations between PVWMH, DWMH, stroke, and dementia were estimated using LDSC. Results: In the discovery and replication analysis, for PVWMH only, we found associations on chromosomes 2 ( NBEAL ), 10q23.1 ( TSPAN14/FAM231A ), and 10q24.33 ( SH3PXD2A). In the much larger combined meta-analysis of all cohorts, we identified ten significant regions for PVWMH: chromosomes 2 (3 regions), 6, 7, 10 (2 regions), 13, 16, and 17q23.1. New loci of interest include 7q36.1 ( NOS3 ) and 16q24.2. In both the discovery/replication and combined analysis, we found genome-wide significant associations for the 17q25.1 locus for both DWMH and PVWMH. Using gene-based association analysis, 19 genes across all regions were identified for PVWMH only, including the new genes: CALCRL (2q32.1), KLHL24 (3q27.1), VCAN (5q27.1), and POLR2F (22q13.1). Thirteen genes in the 17q25.1 locus were significant for both phenotypes. More extensive genetic correlations were observed for PVWMH with small vessel ischemic stroke. There were no associations with dementia for either phenotype. Conclusions: Our study confirms these phenotypes have distinct and also shared genetic architectures. Genetic analyses indicated PVWMH was more associated with ischemic stroke whilst DWMH loci were implicated in vascular, astrocyte, and neuronal function. Our study confirms these phenotypes are distinct neuroimaging classifications and identifies new candidate genes associated with PVWMH only.
Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma
Miller, Kevin C. , Hilger, Crystal, Ryder, Mabel , Smith, Carin Y. , Jenkins, Sarah M. , Bible, Keith C. , Chintakuntlawar, Ashish V , Bancos, Irina , Smith, Carin Y , Bible, Keith C , Ryder, Mabel , Miller, Kevin C , Chintakuntlawar, Ashish V. , Bancos, Irina , Morris, John C

Mayo Clinic

Journal of the Endocrine Society | June 9, 2020 | Volume: 4 | Issue: 7 | Pages: No page available

10.1210/jendso/bvaa069 | PMID 32666013 Get It

Abstract Background Median overall survival is 12 to 15 months in patients with metastatic adrenal cortical carcinoma (ACC). Etoposide, doxorubicin, and cisplatin with or without the adrenolytic agent mitotane is considered the best first-line approach in this context, but has limited activity and no curative potential; additional salvage therapeutic options are needed. Methods Fifteen total patients with recurrent/metastatic ACC were treated with single-agent multikinase inhibitors (MKI) (n = 8), single-agent PD-1 inhibition (n = 8), or cytotoxic chemotherapy plus PD-1 inhibition (n = 4) at our institution as later-line systemic therapies in efforts to palliate disease and attempt to achieve a therapeutic response when not otherwise possible using standard approaches. Results Two of 8 patients (25%) treated with single-agent MKI achieved a partial response (PR), including 1 PR lasting 23.5 months. Another 3 patients (38%) had stable disease (SD); median progression-free survival (PFS) with single-agent MKI was 6.4 months (95% confidence interval [CI] 0.8—not reached). On the other hand, 2 of 12 patients (17%) treated with PD-1 inhibitors (either alone or in combination with cytotoxic chemotherapy) attained SD or better, with 1 patient (8%) achieving a PR; median PFS was 1.4 months (95% CI 0.6-2.7). Conclusions Our single-institution experience suggests that select ACC patients respond to late-line MKI or checkpoint inhibition despite resistance to cytotoxic agents. These treatments may be attractive to ACC patients with limited other therapeutic options. The use of MKI and immunotherapy in ACC warrants prospective investigation emphasizing parallel correlative studies to identify biomarkers that predict for response.
Peripherally inserted central catheter placement in a multidisciplinary intensive care unit: A preliminary study demonstrating safety and procedural time in critically ill subjects
Smith, Ryan J. , Cartin‐Ceba, Rodrigo , Colquist, Julie , Muir, Amy M, Moorhead, Jeanine M, Callisen, Hannelisa, Patel, B. M. , Colquist, Julie A, Callisen, Hannelisa E, Patel, Bhavesh M

Mayo Clinic

The Journal of Vascular Access | June 9, 2020 | Volume: 22 | Issue: 1 | Pages: 101-106

10.1177/1129729820928618 | PMID 32515261 Get It

Objective: Peripherally inserted central catheters are a popular means of obtaining central venous access in critically ill patients. However, there is limited data regarding the rapidity of the peripherally inserted central catheter procedure in the presence of acute illness or obesity, both of which may impede central venous catheter placement. We aimed to determine the feasibility, safety, and duration of peripherally inserted central catheter placement in critically ill patients, including obese patients and patients in shock. Methods: This retrospective cohort study was performed using data on 55 peripherally inserted central catheters placed in a 30-bed multidisciplinary intensive care unit in Mayo Clinic Hospital, Phoenix, Arizona. Information on the time required to complete each step of the peripherally inserted central catheter procedure, associated complications, and patient characteristics was obtained from a prospectively assembled internal quality assurance database created through random convenience sampling. Results: The Median Procedure Time, beginning with the first needle puncture and ending when the procedure is complete, was 14 (interquartile range: 9–20) min. Neither critical illness nor obesity resulted in a statistically significant increase in the time required to complete the peripherally inserted central catheter procedure. Three (5.5%) minor complications were observed. Conclusion: Critical illness and obesity do not delay the acquisition of vascular access when placing a peripherally inserted central catheter. Concerns of delayed vascular access in critically ill patients should not deter a physician from selecting a peripherally inserted central catheter to provide vascular access when it would otherwise be appropriate.
Creation of a New Educational Podcast: “Headmirror’s ENT in a Nutshell”
Barnes, Jason H. , Smith, Alyssa J. , Kiessling, Patrick , Marinelli, John P. , Carlson, Matthew L. , Choby, Garret , Bowe, Sarah N.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | June 9, 2020 | Volume: 163 | Issue: 4 | Pages: 623-625

10.1177/0194599820930662 | PMID 32513092 Get It

Podcasts are online digital audio programs that are disseminated via online subscription that are easily accessible through computers or smartphones. Increasingly, residents and medical students are prioritizing podcasts for asynchronous medical education due to ease of use, convenience (eg, use while exercising or commuting), and repeatability. Some trainees have found podcasts more useful than traditional didactic lectures. Given the increasing requirements of social distancing and the need for distance medical education platforms, podcast production can serve as a useful tool to complement resident and medical student education and is a resource that will remain accessible in perpetuity. An otolaryngology specialty podcast, “Headmirror’s ENT in a Nutshell,” was created to augment asynchronous learning and address the acute need for distance learning opportunities. Over the first 7 weeks of production, 50 episodes were created. Episodes were posted on www.headmirror.com, with subscription services available through Apple Podcast, Spotify, and other platforms.
Incidence and Prognostic Impact of Infection in Patients with Type 1 and 2 Myocardial Infarction
Sandoval, Yader , Sexter, Anne, Schulz, Karen , Apple, Fred S. , Smith, Stephen W.

Mayo Clinic

Clinical Chemistry | June 8, 2020 | Volume: 66 | Issue: 9 | Pages: 1240-1241

10.1093/clinchem/hvaa138 | PMID 32712646 Get It

Isolated Optic Nerve Leukemic Relapse Diagnosed via Fine Needle Aspiration Biopsy and Transconjunctival Biopsy
Smith, Kerri McInnis, Mansueto, Lisa A., Schafernak, Kristian T. , Jacobsen, Jeffrey, Henry, M M , Ramasubramanian, Aparna , Henry, Michael M , Schafernak, Kristian , McInnis‐Smith, Kerri

Mayo Clinic

No container title available | June 8, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.159164631.14999578 Get It

Pre-B cell acute lymphoblastic leukemia (ALL) is a hematologic malignancy that arises from overproduction of immature lymphoid cells. ALL has a propensity for recurring in the bone marrow and/or extramedullary sites following complete remission. We present the case of a young male with a history of pre-B cell ALL who presented with leukemic recurrence isolated to the optic nerve. Transvitreal fine needle aspiration biopsy followed by transconjunctival optic nerve biopsy confirmed the diagnosis of ALL relapse and should be considered helpful diagnostic tools in the setting of suspected optic nerve malignancy with otherwise negative workup.
Sympathetically mediated increases in cardiac output, not restraint of peripheral vasodilation, contribute to blood pressure maintenance during hyperinsulinemia
Limberg, Jacqueline K. , Smith, James , Soares, Rogério N. , Harper, Jennifer L. , Houghton, K., Jacob, Dain W. , Mozer, Michael T., Grunewald, Zachary I., Johnson, Blair D. , Curry, Timothy B. , Padilla, Jaume , Johnson, Blair D , Padilla, Jaume , Houghton, Keeley N., Baynard, Tracy , Manrique‐Acevedo, Camila

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | June 5, 2020 | Volume: 319 | Issue: 1 | Pages: H162-H170

10.1152/ajpheart.00250.2020 | PMID 32502373 Get It

We examined the role of sympathetic activation in restraining vasodilatory responses to hyperinsulinemia and sustaining blood pressure in healthy adults. Data are reported from two separate experimental protocols in humans and one experimental protocol in isolated arteries from mice. Contrary to our hypothesis, the present findings support the idea that during hyperinsulinemia, a sympathetically mediated increase in cardiac output, rather than restraint of peripheral vasodilation, is the principal contributor to the maintenance of systemic blood pressure.